Ravi Doddapaneni

Carolinas Medical Center — United States

Materials Science · Physical Sciences

22h-index1.3kcitations52works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoparticle-Based Drug Delivery(8), Nuclear Receptors and Signaling(8), Salivary Gland Tumors Diagnosis and Treatment(7), RNA Interference and Gene Delivery(6), Nanoplatforms for cancer theranostics(6)

Publications52 total

Abstract B040: Combined treatment and metabolomics reveal mechanism underlying the synergy of ribitol and shikonin against breast cancer
Molecular Cancer Therapeutics·2025
Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells
International Journal of Molecular Sciences·2025· 3 citedOpen Access
Metabolic Reprogramming by Ribitol Expands the Therapeutic Window of BETi JQ1 against Breast Cancer
Cancers·2023· 4 citedOpen Access
Mass spectrometry database of lacrimal gland adenoid cystic carcinoma and normal lacrimal gland tissue identifies extracellular matrix remodeling in these tumors
Data in Brief·2023Open Access
Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer
PLoS ONE·2022· 18 citedOpen Access
Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line
Translational Vision Science & Technology·2021· 9 citedOpen Access
Characterization of Ephrin Receptor Activation in Hereditary and Traumatic Optic Neuropathy Models
Investigative Ophthalmology & Visual Science·2020Open Access
Abstract 3832: Synergistic anticancer effects of epigenetic drugs JQ1 and SAHA in adenoid cystic carcinoma of the lacrimal gland
Experimental and Molecular Therapeutics·2019
Abstract 3832: Synergistic anticancer effects of epigenetic drugs JQ1 and SAHA in adenoid cystic carcinoma of the lacrimal gland
Cancer Research·2019
Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells
AAPS PharmSciTech·2019· 25 citedOpen Access
Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland
Oncotarget·2019· 22 citedOpen Access
The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy
Investigative Ophthalmology & Visual Science·2018· 29 citedOpen Access
AZD4547 fibroblast growth factor receptor-1 inhibitor as a potential drug target for lacrimal gland adenoid cystic carcinoma
Investigative Ophthalmology & Visual Science·2018Open Access
Modulation of Eph-receptor signaling: implications for neurodegenerative disease and neural regeneration
2018
The role of MYB and NOTCH in the oncogenesis of adenoid cystic carcinoma of the lacrimal gland
Investigative Ophthalmology & Visual Science·2018Open Access
A xenograft model for lacrimal gland adenoid cystic carcinoma in mice
Investigative Ophthalmology & Visual Science·2018Open Access
Sebaceous Carcinoma of the Eyelid
2018
Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer
Pharmacological Research·2017· 17 citedOpen Access
Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer
Scientific Reports·2017· 38 citedOpen Access
Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer
AAPS PharmSciTech·2017· 35 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Mandip Singh(25), Ketan Patel(14), Chandraiah Godugu(11), Daniel Pelaez(11), Stephen Safe(10), Apurva R. Patel(9), Nusrat Chowdhury(9), Wensi Tao(9), Cedar H. A. Boakye(8), David T. Tse(7), Srujan Marepally(4), Arvind Bagde(4), Erik Hedrick(4), Mandip Sachdeva(4), Syng‐Ook Lee(3), Gautam Behl(3), Anuradha Chakraborti(3), Catherine J. Choi(3), Jason D. Tucker(3), Pei Lu(3)